Element Capital Management LLC Cytom X Therapeutics, Inc. Transaction History

Element Capital Management LLC

  • $2.17 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018
SELL
$18.04 - $26.41 $389,772 - $570,614
-21,606 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$21.38 - $29.68 $104,355 - $144,868
4,881 Added 29.18%
21,606 $494,000
Q1 2018

May 15, 2018
BUY
$21.76 - $34.22 $363,936 - $572,329
16,725 New
16,725 $476,000

Others Institutions Holding CTMX

# of Institutions
68
Shares Held
50.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $66M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Element Capital Management LLC Portfolio

Follow Element Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email